Bioanalysis for
Animal Health
Comprehensive GLP bioanalytical services for veterinary drug development, bioequivalence, and residue depletion studies.
Scientific Rigor for Veterinary Medicines
Veterinary medicines require the same scientific rigor and regulatory precision as human therapeutics but demand unique analytical approaches adapted to diverse species, complex matrices, and specific regulatory frameworks.
At BrownBiology Laboratory, we provide GLP-compliant bioanalytical services dedicated to Animal Health, supporting the development of innovative products, bioequivalence, and residue depletion studies of veterinary drugs. Our multidisciplinary teams combine extensive LC-MS/MS expertise with a deep understanding of veterinary-specific regulations to deliver reliable data for global submissions.
Operating under GLP certification and inspected by both the EMA and FDA.
MAIN Services
BrownBiology supports veterinary drug development with GLP-compliant bioanalytical services across all key study types. Our expertise ensures reliable, regulatory-compliant data.
Residue Depletion Studies
Ensure food safety standards through international compliance.
- GLP analysis to establish withdrawal periods.
- Determine maximum residue limits (MRLs).
- Follow VICH GL49 (2012) regulations.
- Assure compliance with food safety standards.
Bioequivalence Studies
Establish equivalence for generic veterinary products.
- Demonstrate equivalence against reference products.
- Implement EMA/FDA-validated bioanalytical methods.
- High-throughput sample analysis.
- Robust cross-species data generation.
Additional Support Services
Extensive preclinical and clinical veterinary support.
- Pharmacokinetic and toxicokinetic (PK/TK) studies.
- Metabolite identification and characterization.
- Stability testing and storage monitoring.
- Method transfer and cross-validation.
Our Experience
Our bioanalytical teams have extensive experience working with a wide range of target animal species. This diversity allows us to adapt our methods to the specific physiological and regulatory requirements of each species, ensuring robust, compliant data generation.
Target Animal Species
Matrices and Sample Expertise
Why Choose BrownBiology?
Regulatory Excellence
Compliance with VICH GL49 (2012) for residue depletion and EMA/FDA bioanalytical validation guidelines for PK and bioequivalence ensures global regulatory acceptance.
GLP-Certified & Inspected
Our laboratories operate under GLP, inspected by EMA and FDA, guaranteeing the reliability and reproducibility of all analytical data.
Advanced Analytical Platforms
State-of-the-art LC-MS/MS instrumentation enables ultra-sensitive quantification of drugs, metabolites, and residues in complex matrices.
Trusted by Global Leaders
We partner with leading veterinary pharmaceutical companies to support drug approvals, residue depletion studies, and bioequivalence programs.
Our One-Stop-Shop Solution
At BrownBiology, we offer a streamlined, end-to-end solution for veterinary studies. Through strategic partnerships with GLP-certified in-vivo centers, we manage the full package, from in-life dosing to sample analysis and reporting.